Top Stories: Page 49

Outliers in Florida's Cannabis Market

The Sunshine State’s growing medical cannabis market doesn’t always align with national trends, and it is one to watch as advocates push for adult use.

Alabama Awards 20 Medical Cannabis Licenses in Yet Another Do-Over

The state’s regulators are hoping the third time is the charm to ignite a commercial marketplace for patients with qualifying conditions.

WATCH: How One Small Trellis Netting Change Can Save Money, Time in Cannabis Cultivation

After Denver-based Clarity Gardens adjusted how it attaches trellis netting in its cannabis cultivation facility, the company realized cost and labor savings, plus increased plant quality.

Consumer and Sales Trends in the Second Largest US Cannabis Market

On the four-year anniversary of adult-use sales in Michigan, consumer purchasing trends reveal insights about top brands, product categories, illicit market competition and more.

The Fall of Grassdoor: California-Based Cannabis Delivery Giant Begins Insolvency Proceedings, Ceases Operations

Interim CEO Chi-Chien Hou delivered the news Nov. 21 to employees, who were all laid off “effective immediately.”

Michigan’s 4-Year Adult-Use Sales Anniversary: A Visual Recap

The Top 10: CBT's Most-Read Articles in November

Here's a recap and list of the stories readers engaged most with this month.

New York Regulators Approve Settlement Agreement Allowing Dispensary Openings to Resume

The agreement between the Office of Cannabis Management and the plaintiffs, which is pending court approval, would allow licensees on hold under a temporary injunction to proceed with their business plans.

Where the Ladybugs Fly: Behind Autumn Brands’ No-Spray Cannabis Cultivation

The sixth-generation family operator puts its 100% biocontrol program and sustainability at the forefront of its integrative growing techniques.

Federal Government Continues to Withhold Key Cannabis Scheduling Recommendation Letter Despite FOIA Requests, Lawsuit

After nearly three months and multiple Freedom of Information Act requests, the U.S. Department of Health and Human Services still has not publicly confirmed that it recommended cannabis be reclassified as a Schedule III controlled substance. One attorney who filed a lawsuit to obtain the letter calls the situation "asinine" and "profoundly disappointing."

As Ohio Legalizes Cannabis, the State’s Junior US Senator Opposes SAFER Banking for Industry

The “upsides of this bill are overstated,” Sen. JD Vance said about providing federal safe harbor to banks servicing state-sanctioned cannabis companies.

New York Cannabis Sales Eclipse $100M as Missouri Passes $1 Billion in 2023

The Empire State’s regulated adult-use retail market has struggled to pick up steam with a mere 27 operators licensed for commercial sales.

Previous Page

Page 49 of 253

Next Page